These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 19031966)

  • 1. Fatal thrombocytopenia after oxaliplatin-based chemotherapy.
    Shao YY; Hong RL
    Anticancer Res; 2008; 28(5B):3115-7. PubMed ID: 19031966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypersensitivity reactions to oxaliplatin in two asian patients.
    Ng CV
    Ann Pharmacother; 2005 Jun; 39(6):1114-8. PubMed ID: 15886290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxaliplatin-induced immune mediated thrombocytopenia.
    Beg MS; Komrokji RS; Ahmed K; Safa MM
    Cancer Chemother Pharmacol; 2008 Oct; 62(5):925-7. PubMed ID: 18204841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute pain associated with oxaliplatin infusion: case report and literature review.
    Clay TD; Ashley DA
    J Oncol Pharm Pract; 2012 Dec; 18(4):421-4. PubMed ID: 22080592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatal diffuse alveolar damage associated with oxaliplatin administration.
    Watkins J; Slade JH; Phan A; Eng C; Weissferdt A; Overman MJ
    Clin Colorectal Cancer; 2011 Sep; 10(3):198-202. PubMed ID: 21855043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is oxaliplatin combined with weekly bolus 5-fluorouracil and leucovorin an option for stage II and III colon cancer?
    Twelves C
    Nat Clin Pract Oncol; 2008 Feb; 5(2):72-3. PubMed ID: 18030299
    [No Abstract]   [Full Text] [Related]  

  • 7. 5FU and oxaliplatin-containing chemotherapy in two dihydropyrimidine dehydrogenase-deficient patients.
    Reerink O; Mulder NH; Szabo BG; Hospers GA
    Anticancer Res; 2004; 24(3b):1969-71. PubMed ID: 15274386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent priapism related to oxaliplatin infusion.
    Adenis A; Mailliez A; Rigot JM; Gamelin L; Vanhuyse M; Gamelin E
    J Clin Oncol; 2008 Feb; 26(6):1016-7. PubMed ID: 18281680
    [No Abstract]   [Full Text] [Related]  

  • 9. Middle-Aged Man With Acute Thrombocytopenia Subsequent to Fluorouracil and Oxaliplatin Chemotherapy for Colorectal Cancer.
    Schade H; Davis L; Kabos P
    Oncology (Williston Park); 2016 Nov; 30(11):992-4, 1000-1. PubMed ID: 27854101
    [No Abstract]   [Full Text] [Related]  

  • 10. Oxaliplatin combined with continuous infusion of 5-fluorouracil as first-line chemotherapy in patients with metastatic or recurrent gastric adenocarcinoma.
    Lim JY; Cho JY; Oh KJ; Choi SH; Lee SI; Jeung HC
    Chemotherapy; 2009; 55(4):200-6. PubMed ID: 19451710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small-cell cancers, and an unusual reaction to chemotherapy: Case 4. Fluorouracil-related small bowel vasculitis.
    Bucaloiu ID; Dubagunta S; Pachipala KK; Kamal N; Fata F
    J Clin Oncol; 2003 Jun; 21(12):2442-3. PubMed ID: 12805347
    [No Abstract]   [Full Text] [Related]  

  • 12. Oxaliplatin-induced haematological emergency with an immediate severe thrombocytopenia and haemolysis.
    Sørbye H; Bruserud Y; Dahl O
    Acta Oncol; 2001; 40(7):882-3. PubMed ID: 11859992
    [No Abstract]   [Full Text] [Related]  

  • 13. Oxaliplatin hypersensitivity: case report and successful repeat desensitization.
    Edmondson DA; Gruling BJ; Urmanski AM; Wong SJ; Levy MB
    Am J Ther; 2007; 14(1):116-8. PubMed ID: 17303980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute inflammatory demyelinating polyradiculoneuropathy in a patient receiving oxaliplatin-based chemotherapy.
    Yoon JY; Nam TS; Kim MK; Hwang JE; Shim HJ; Cho SH; Chung IJ; Bae WK
    Asia Pac J Clin Oncol; 2012 Jun; 8(2):201-4. PubMed ID: 22524580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful desensitization to oxaliplatin with incorporation of calcium gluconate and magnesium sulfate.
    Wrzesinski SH; McGurk ML; Donovan CT; Ferencz TM; Saif MW
    Anticancer Drugs; 2007 Jul; 18(6):721-4. PubMed ID: 17762403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and characteristics of peripheral neuropathy during oxaliplatin-based chemotherapy for metastatic colon cancer.
    Argyriou AA; Polychronopoulos P; Iconomou G; Koutras A; Makatsoris T; Gerolymos MK; Gourzis P; Assimakopoulos K; Kalofonos HP; Chroni E
    Acta Oncol; 2007; 46(8):1131-7. PubMed ID: 17851880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxaliplatin-related acute disseminated intravascular coagulation syndrome in a patient with metastatic colon cancer.
    Malkhasyan K; Halene S; Lacy J
    Clin Colorectal Cancer; 2015 Mar; 14(1):e9-e12. PubMed ID: 25446051
    [No Abstract]   [Full Text] [Related]  

  • 18. Desensitization to oxaliplatin with two stages of premedication in a patient with metastatic rectal cancer.
    Nozawa H; Muto Y; Yamada Y
    Clin Ther; 2008 Jun; 30(6):1160-5. PubMed ID: 18640472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxaliplatin-mediated autoimmune thrombocytopenia.
    Saif MW; The A; Ledbetter L
    Clin Colorectal Cancer; 2009 Jan; 8(1):61-2. PubMed ID: 19203900
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical features of hypersensitivity reactions to oxaliplatin: a 10-year experience.
    Polyzos A; Tsavaris N; Gogas H; Souglakos J; Vambakas L; Vardakas N; Polyzos K; Tsigris C; Mantas D; Papachristodoulou A; Nikiteas N; Karavokyros JG; Felekouras E; Griniatsos J; Giannopoulos A; Kouraklis G
    Oncology; 2009; 76(1):36-41. PubMed ID: 19033714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.